• METTL3–m6A–LEPR Axis in Fetal Growth Restriction

  2026-08-15

  A 2026 Placenta study identifies a METTL3-dependent m6A–LEPR regulatory axis that links RNA modification to trophoblast dysfunction and fetal growth restriction. Human placental analysis, mouse pharmacological inhibition, RNA sequencing, and trophoblast assays together suggest that reduced METTL3 activity and LEPR methylation may impair placental growth-related functions.

• Cisapride in iPSC-CM Cardiotoxicity Assays

  2026-08-14

  Cisapride (R 51619) is a useful dual-axis probe for connecting 5-HT4 signaling with hERG-related electrophysiology. This guide shows how to interpret it in iPSC-cardiomyocyte and deep-learning-enabled cardiotoxicity workflows without confusing phenotypic detection with mechanism.

• Imipenem P10075 for Reliable Cell Assays

  2026-08-14

  Learn how Imipenem (SKU P10075) can help laboratories control antibacterial variables in viability, proliferation, cytotoxicity, and immune-cell assays. This scenario-based guide connects formulation, dosing, storage, and carbapenem-resistance evidence to practical experimental decisions.

• PRINT: RNA-Mediated Safe-Harbor Transgene Insertion

  2026-08-13

  The reference study introduces PRINT, an RNA-only strategy that uses avian R2 retroelement proteins to insert transgenes at a multicopy human safe-harbor locus through target-primed reverse transcription. Its main contribution is a mechanistically distinct alternative to DNA-break repair and viral delivery, although broader cell-type validation, insertion-site profiling, and long-term functional studies remain necessary.

• From miRNA Mechanism to Reliable Placental Assays

  2026-08-13

  A translational framework connecting the miR-185-5p–CDC42 inflammatory axis in gestational diabetes research with rigorous mouse IgG immunodetection, assay controls, and strategic workflow design.

• Dabigatran etexilate: Applied Assay Workflows

  2026-08-12

  Dabigatran etexilate enables mechanism-focused thrombin assays, coagulation-panel profiling, and translational anticoagulant research. This guide turns its low-nanomolar potency and oral prodrug biology into practical workflows with defined controls, solvent guidance, and troubleshooting steps.

• Stat3–NF-κB Signaling in Fyn-Driven Neurodegeneration

  2026-08-12

  A 2024 Disease Models & Mechanisms study uses a neural-specific zebrafish model of constitutively active Fyn to connect dopaminergic neuron loss with microglial inflammation. The work identifies Stat3 as a previously underdefined downstream effector and shows that Stat3 and NF-κB cooperate in Fyn-driven neurodegeneration, providing a mechanistic framework for pathway-focused experiments.

• Oteseconazole: From MIC to DDI-Aware Assays

  2026-08-11

  Oteseconazole (VT-1161) is examined here through a translational lens that connects Candida susceptibility testing with enzyme- and transporter-mediated drug-interaction evidence. The article provides a practical, DDI-aware framework for designing and interpreting antifungal research assays.

• Heparin sodium for Coagulation and Nanovesicle Assays

  2026-08-11

  Heparin sodium provides a practical anticoagulant benchmark for anti-factor Xa activity assays, activated partial thromboplastin time measurements, and thrombosis models. This guide also shows how to use it as an exploratory perturbation when investigating heparan sulfate proteoglycan-dependent uptake of plant-derived nanovesicles, while clearly separating established evidence from emerging assay ideas.

• Tranexamic Acid in Fibrinolysis Research

  2026-08-10

  Translate plasmin inhibition into reproducible clot-stabilization, neutrophil-adherence, plasma, and biomaterial assays with practical concentration controls. The reference study shows how Tranexamic Acid can be incorporated into a bilayer dressing strategy while preserving clear separation between antifibrinolytic and antibacterial effects.

• Heparin sodium in Nanovesicle Uptake Assays

  2026-08-09

  Heparin sodium supports two complementary workflows: controlled anticoagulation for coagulation and thrombosis experiments, and a carefully bounded competition strategy for studying heparan sulfate proteoglycan-dependent nanovesicle uptake. This guide connects those uses to a recent Sertoli-cell study while emphasizing controls, matrix effects, and research-only interpretation.

• Cisapride in Cardiac Electrophysiology Research

  2026-08-08

  Cisapride (R 51619) offers a dual-purpose perturbation for connecting 5-HT4 receptor signaling with hERG channel inhibition in human cardiac models. This workflow shows how to combine controlled dosing, iPSC-derived cardiomyocytes, high-content imaging, and orthogonal electrophysiology to investigate arrhythmogenic phenotypes without mistaking a screening signal for mechanism.

• Merimepodib (VX-497) IMPDH Workflows

  2026-08-07

  Merimepodib (VX-497) turns IMPDH-dependent guanine nucleotide metabolism into a practical experimental control point for antiviral, immune-cell, and cancer research. This guide connects PEDV host-metabolism findings with assay design, rescue experiments, dosing workflows, and troubleshooting strategies.

• Cisplatin Resistance: Mechanistic Frontiers & Translational

  2026-08-07

  Explore cutting-edge mechanistic insights into Cisplatin (CDDP) resistance, linking DNA damage, apoptosis, and ferroptosis regulation with actionable strategies for translational cancer researchers. This thought-leadership article integrates recent evidence on PI3K/MDM2/p53 signaling, highlights competitive research frontiers, and provides protocol parameters for robust experimental design. Internal links and product intelligence contextualize APExBIO's Cisplatin within the evolving oncology landscape.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-08-06

  Erastin from APExBIO empowers researchers to dissect ferroptosis in RAS/BRAF-mutant tumor models with high specificity and reproducibility. Discover detailed workflows, experimental optimizations, and troubleshooting strategies that unlock new frontiers in cancer biology and oxidative stress assays.

16327 records 1/1089 page Next 12345 下5页 Last page